Alert Done Done Edit In progress Play Run workshop Download Down Close All modules Educator In progress Learner How to Delete Information Credits Undo Time Left Right Right Down Locked Hide Home Menu Twitter LinkedIn icons.facebook Plus
Professor Philip Newsome

Professor Philip Newsome

Professor of Hepatology, University of Birmingham, United Kingdom

Professor Newsome runs the metabolic services at the Liver Unit at the Queen Elizabeth Hospital Birmingham which includes a large multi-disciplinary clinic for patients with NAFLD. He was Chief Investigator on a randomised controlled trial of Glucagon-like peptide-1 (GLP-1) therapies in NAFLD published in the Lancet and the NEJM. He is the Co-ordinating Investigator for several global NAFLD studies. He chaired the national guidelines for liver transplantation in NAFLD and sat on the NICE Guideline Development Group for NAFLD. He led the recent UK multi-stakeholder guideline group on the management of abnormal liver blood tests and led on NAFLD for the recent EASL Lancet Liver Commission.  He recently completed his term as Secretary General (President) of EASL. 

Associated Modules

CME Credits: 0.25

NASH and type 2 diabetes: A podcast mini-series

In this podcast series, we look into the importance of considering the potential presence of NASH during type 2 diabetes management